CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities
Net income	$ 232,758	$ 214,840	$ 145,122
Reconciliation of net income to net cash provided by operating activities:
Depreciation and amortization	60,438	65,045	34,124
Deferred financing cost amortization	1,120	4,514	165
Stock-based compensation	22,888	18,105	10,631
Provision for expected credit losses	370	2,622	406
Inventory obsolescence	3,841	5,337	2,739
Gain on disposal of assets	(1,013)	(3,156)	(1,391)
Deferred income taxes	19,773	17,343	25,299
Change in fair value of earn-out liability	16,318	14,850	0
(Gain) loss from revaluation of liability related to tax receivable agreement	(3,204)	(4,490)	1,910
Changes in operating assets and liabilities:
Accounts receivable	13,048	(11,858)	(49,349)
Inventories	(25,628)	41,922	(44,891)
Prepaid expenses and other assets	(2,267)	753	(3,108)
Accounts payable	675	8,710	5,803
Accrued expenses and other liabilities	28,964	(7,367)	2,090
Payments pursuant to tax receivable agreement	(20,800)	(26,890)	(11,666)
Payment of earn-out liability	(31,168)	0	0
Net cash provided by operating activities	316,113	340,280	117,884
Cash flows from investing activities
Acquisition of a business, net of cash and cash equivalents acquired	0	(616,189)	0
Capital expenditures and other	(39,176)	(43,977)	(28,291)
Proceeds from sale of assets	3,788	5,373	2,755
Net cash used in investing activities	(35,388)	(654,793)	(25,536)
Cash flows from financing activities
Proceeds from the issuance of long-term debt	0	155,000	0
Repayments of borrowings of long-term debt	0	(155,000)	0
Payment of contingent consideration	(5,960)	0	0
Net proceeds from the issuance of Class A common stock	0	169,878	0
Payments of deferred financing costs	0	(6,934)	(353)
Payments on finance leases	(7,882)	(7,652)	(6,055)
Dividends paid to Class A common stock shareholders	(33,681)	(30,124)	(26,719)
Distributions to members	(13,290)	(16,644)	(9,692)
Repurchases of shares	(9,331)	(5,249)	(4,563)
Net cash provided by (used in) financing activities	(70,144)	103,275	(47,382)
Effect of exchange rate changes on cash and cash equivalents	(1,530)	503	(2,108)
Net increase (decrease) in cash and cash equivalents	209,051	(210,735)	42,858
Cash and cash equivalents
Beginning of period	133,792	344,527	301,669
End of period	$ 342,843	$ 133,792	$ 344,527